OverviewSuggest Edit

Nuvaira develops devices for treating lung diseases. The Company is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease.

TypePrivate
Founded2008
HQPlymouth, US
Websitenuvaira.com

Latest Updates

Employees (est.) (Oct 2019)46

Nuvaira Office Locations

Nuvaira has an office in Plymouth
Plymouth, US (HQ)
3750 Annapolis Ln N #105
Show all (1)

Nuvaira Financials and Metrics

Summary Metrics

Founding Date

2008

Nuvaira total Funding

$147.6 m

Nuvaira latest funding size

$79 m

Time since last funding

8 months ago

Nuvaira investors

Nuvaira's latest funding round in February 2019 was reported to be $79 m. In total, Nuvaira has raised $147.6 m
Show all financial metrics

Nuvaira Online and Social Media Presence

Embed Graph

Nuvaira News and Updates

Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, May 2, 2019 /PRNewswire/ -- Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, the French health technology...

Nuvaira Blogs

Nuvaira Announces Peer-Reviewed Publications of Targeted Lung Denervation Mechanisms of Action and Clinical Outcomes

AIRFLOW-2 randomized, sham-controlled one-year data accepted by AJRCCM MINNEAPOLIS, Aug 19, 2019 – Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announced today multiple peer-reviewed publications that provide further evidence of the safety, clinical effect…

First patients successfully treated in the Nuvaira AIRFLOW-3 COPD pivotal trial

A first for Temple University Hospital and U.S. Patients MINNEAPOLIS, June 10, 2019 – Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, announced the first treatments in the AIRFLOW-3 pivotal trial, the first interventional COPD trial to target reduction in COPD …

Nuvaira Frequently Asked Questions

  • When was Nuvaira founded?

    Nuvaira was founded in 2008.

  • How many employees does Nuvaira have?

    Nuvaira has 46 employees.

  • Who are Nuvaira competitors?

    Competitors of Nuvaira include Retrophin, Palatin Technologies and Kineta.

  • Where is Nuvaira headquarters?

    Nuvaira headquarters is located at 3750 Annapolis Ln N #105, Plymouth.

  • Where are Nuvaira offices?

    Nuvaira has an office in Plymouth.

  • How many offices does Nuvaira have?

    Nuvaira has 1 office.